These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 16762036)

  • 1. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage.
    Kurz T; Gustafsson B; Brunk UT
    FEBS J; 2006 Jul; 273(13):3106-17. PubMed ID: 16762036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relocalized redox-active lysosomal iron is an important mediator of oxidative-stress-induced DNA damage.
    Kurz T; Leake A; Von Zglinicki T; Brunk UT
    Biochem J; 2004 Mar; 378(Pt 3):1039-45. PubMed ID: 14670081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIH--a novel lipophilic iron chelator--protects H9c2 cardiomyoblasts from oxidative stress-induced mitochondrial injury and cell death.
    Simůnek T; Boer C; Bouwman RA; Vlasblom R; Versteilen AM; Sterba M; Gersl V; Hrdina R; Ponka P; de Lange JJ; Paulus WJ; Musters RJ
    J Mol Cell Cardiol; 2005 Aug; 39(2):345-54. PubMed ID: 15978614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chelation of lysosomal iron protects against ionizing radiation.
    Berndt C; Kurz T; Selenius M; Fernandes AP; Edgren MR; Brunk UT
    Biochem J; 2010 Dec; 432(2):295-301. PubMed ID: 20846118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron-dependent lysosomal destabilization initiates silica-induced apoptosis in murine macrophages.
    Persson HL
    Toxicol Lett; 2005 Nov; 159(2):124-33. PubMed ID: 15949905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of compartmentalized redox-active iron in hydrogen peroxide-induced DNA damage and apoptosis.
    Tenopoulou M; Doulias PT; Barbouti A; Brunk U; Galaris D
    Biochem J; 2005 May; 387(Pt 3):703-10. PubMed ID: 15579135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against hydrogen peroxide-mediated cytotoxicity in Friedreich's ataxia fibroblasts using novel iron chelators of the 2-pyridylcarboxaldehyde isonicotinoyl hydrazone class.
    Lim CK; Kalinowski DS; Richardson DR
    Mol Pharmacol; 2008 Jul; 74(1):225-35. PubMed ID: 18424550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of hydrogen peroxide-induced apoptosis of human peripheral T cells by a lysosomotropic iron chelator, ammonium chloride.
    Ogawa Y; Kobayashi T; Kariya S; Nishioka A; Nakayama K; Seguchi H; Yoshida S
    Int J Mol Med; 2004 Dec; 14(6):1007-13. PubMed ID: 15547666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of oxidant-induced cell death by lysosomotropic iron chelators.
    Persson HL; Yu Z; Tirosh O; Eaton JW; Brunk UT
    Free Radic Biol Med; 2003 May; 34(10):1295-305. PubMed ID: 12726917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-alpha preserves lysosomal stability in macrophages: a potential defense against oxidative lung injury.
    Persson HL; Vainikka LK
    Toxicol Lett; 2010 Feb; 192(2):261-7. PubMed ID: 19900513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl and ethyl ketone analogs of salicylaldehyde isonicotinoyl hydrazone: novel iron chelators with selective antiproliferative action.
    Macková E; Hrušková K; Bendová P; Vávrová A; Jansová H; Hašková P; Kovaříková P; Vávrová K; Simůnek T
    Chem Biol Interact; 2012 May; 197(2-3):69-79. PubMed ID: 22521999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron chelation with salicylaldehyde isonicotinoyl hydrazone protects against catecholamine autoxidation and cardiotoxicity.
    Hašková P; Kovaříková P; Koubková L; Vávrová A; Macková E; Simůnek T
    Free Radic Biol Med; 2011 Feb; 50(4):537-49. PubMed ID: 21147217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysosomal labilization.
    Terman A; Kurz T; Gustafsson B; Brunk UT
    IUBMB Life; 2006 Sep; 58(9):531-9. PubMed ID: 17002981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron.
    Kurz T; Terman A; Brunk UT
    Arch Biochem Biophys; 2007 Jun; 462(2):220-30. PubMed ID: 17306211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal redox-active iron is important for oxidative stress-induced DNA damage.
    Kurz T; Leake A; von Zglinicki T; Brunk UT
    Ann N Y Acad Sci; 2004 Jun; 1019():285-8. PubMed ID: 15247030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-lipoic acid and alpha-lipoamide prevent oxidant-induced lysosomal rupture and apoptosis.
    Persson HL; Svensson AI; Brunk UT
    Redox Rep; 2001; 6(5):327-34. PubMed ID: 11778851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The radioprotective agent, amifostine, suppresses the reactivity of intralysosomal iron.
    Yu Z; Eaton JW; Persson HL
    Redox Rep; 2003; 8(6):347-55. PubMed ID: 14980067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death.
    Terman A; Gustafsson B; Brunk UT
    Chem Biol Interact; 2006 Oct; 163(1-2):29-37. PubMed ID: 16737690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.